1 / 26

HIV Testing for CDC PS 12-1201 Prevention Grant

HIV Testing for CDC PS 12-1201 Prevention Grant. Welcome. Presentation w/participants on mute (*6) Questions may be submitted via chat throughout presentation Please submit questions to “everyone” using the chat drop down box Discussion & Q/A

petunia
Download Presentation

HIV Testing for CDC PS 12-1201 Prevention Grant

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. HIV Testing for CDC PS 12-1201 Prevention Grant

  2. Welcome • Presentation w/participants on mute (*6) • Questions may be submitted via chat throughout presentation • Please submit questions to “everyone” using the chat drop down box • Discussion & Q/A • We will read questions submitted via chat and respond after the presentation • You may unmute your phone to ask questions during the discussion at the end • Recorded Webinar will be posted on OA’s website • Questions will be added to FAQ • If you encounter any technical difficulties, please contact Pete Ramirez at (916) 445-5702 or email Pete.Ramirez@cdph.ca.gov Fidel Encarnacion at (916) 893-9933 or email Fidel.Encarnacion@cdph.ca.gov

  3. Goals of HIV Testing Webinar • Present OA Testing Goals for CDC 12-1201 • Define HIV Testing Terms • Share OA’s objectives and strategies forCDC 12-1201 HIV Testing • Answer Questions about the formulationof OA’s Testing Plan

  4. HIV Testing in Healthcare / Clinical Settings CDC PS12-1201 - Category A OA’s Goal: Assist healthcare/clinical settings achieve integrated, sustainable HIV testing so that all patients have the opportunity to know their HIV status.

  5. CDC HIV Testing Definitions HIV Screening – providing HIV testing to patients regardless of their behavioral risk or presence of signs and symptoms of HIV infection. Opt-out Testing – notifying a patient that an HIV test will be performed unless the patient declines testing. Recommended HIV Testing Definitions and Examples - http://www.cdc.gov/hiv/topics/funding/PS121201/pdf/Attachment-II.pdf

  6. Testing in HCS (2) • Routine HIV Testing – HIV testing that is a usual and customary medical care practice based on an established protocol or policy. • Healthcare Setting / Clinical (HCS) – a setting in which both medical diagnostic and treatment services are provided. • Non-Healthcare Setting / Non-Clinical – a setting that does not provide both medical diagnostic and treatment services, i.e., OA-funded HIV testing sites.

  7. OA Strategy for HIV Testing in Healthcare Settings CDC PS12-1201 - Category A • Assist LHJs to create inventory of current HIV testing in HCSs. • Assist LHJs in encouraging HCSs to implement routine, opt-out HIV testing. • Provide TA to LHJs and HCSs related to: • testing methodology • clinic work flow • reimbursement • data collection and submission • OA to develop best practices for HIV testing in HCSs. Please note: OA-provided HIV testing kits cannot be used for routine, opt-out testing in HCSs.

  8. Consent for HIV Testing • Written consent is not required for HIV testing ordered by a healthcare provider in HCSs. • Provide specific information orally or in writing. http://www.cdph.ca.gov/pubsforms/forms/CtrldForms/cdph8700.pdf • Written consent is required for HIV testing that is performed (specimen collection, processing and/or results provision) by OA-certified HIV Test Counselors.

  9. Reimbursement • AB 1894 – all private health insurance third-party payers must reimburse for HIV testing regardless of primary diagnosis. • Medi-Cal should reimburse for ICD-9-CM diagnosis codes V73.89 (Special screening for other specified viral diseases) or V69.8 (Other problems related to lifestyle). • Family PACT (Planning, Access, Care, Treatment) will reimburse for routine HIV screening. • Medicare will reimburse for individual risk factors and if the patient requests an HIV test.

  10. HIV Testing in Non-Healthcare Settings

  11. Hiv Testing in NoN-Healthcare Settings as defined by the cdc • “A setting where neither medical diagnostic nor treatment services are provided but health screenings are provided.” • Examples of testing in a non-healthcare (non-clinical) setting are: • OA Funded HIV Testing Sites • Field Testing • Syringe Exchange Program

  12. Program Shift • Alignment with National HIV/AIDS Strategy • OA maximizing its available resources to focus on testing efforts that yield an increase in numbers of newly-identified people with HIV infection who know their infection status

  13. Testing objective • OA will increase the numbers of high risk (targeted) clients tested by 10 percent by year end 2012. • LHJs will target their testing efforts to • African American • Latino • MSM • Transgender Individuals • IDUs • And Partners of All Listed Groups

  14. Testing objective • OA will increase the numbers of newly- identified HIV positive clients who access medical care and receive Partner Services. • LHJs will continue to be required to provide • Linkage to Care • Verified Medical Visit • Partner Services

  15. Testing approach • Over the next 18 months, OA will work closely with funded LHJs to implement strategies to increase HIV testing which targets specified targeted (high risk) populations in non-healthcare settings. • OA has reviewed data of testing efforts made by funded LHJs to targeted populations. • OA will assist LHJs focus their testing activities to targeted populations and reduce testing in sites with low positivity rates.

  16. Testing approach • Jurisdictions and agencies should consider which strategy or combination of strategies work best given the epidemiological characteristics of HIV infection in their area. • With OA assistance, LHJs will be asked to define ways to reach targeted populations focusing on C&T, surveillance, and 2010 census data.

  17. OA Testing Support • Rapid HIV test kits and controls • HIV testing forms and lab slips • HIV Counselor training • Data management by LEO • Indicator reports • Technical Assistance • Program monitoring

  18. Updates in Testing program • HIV counselor curriculum is being updated. • HCV testing and training for counselors. New legislation (AB 1382) effective January 1, 2012. • Preliminary positives can be referred to HIV care for confirmatory testing. http://www.cdph.ca.gov/programs/aids/Documents/HIVTestingConfTestiGuidance.pdf

  19. Testing Data

  20. Leo update • Local Evaluation Online • All testing data will go into LEO • CDC’s new reporting requirement – long-term changes • New LEO Testing Indicators Report (#14) • Key report to monitor your program • Positive test results, referrals to care, verified medical visit, and Partner Services • Gender, race/ethnicity, age groups • Risk level, (high or low), risk groups • Are you new to LEO? – help is on the way. An Operations Advisor will be assigned to assist you.

  21. Leo customized reports • Program planning and evaluation, needs assessment, community planning, grants/proposals • Customized Testing Indicators Report (#14) (e.g., agencies, locations, location type, residence ZIP code, testing strategy, target populations) • Request for HIV Prevention Program Reports Form • Please allow at least two to four weeks for completion

  22. Leo data and information sources • Prevention data files • Excel, SPSS, SAS • LEO Data File Request Form • Please allow at least five business days for completion. • Surveillance data • HIV/AIDS surveillance reports & data requests • Request for HIV/AIDS Summary Data (Please allow 60 days for completion.) • Know your target populations and community • OA website – OA’s EPI profile • US Census website – factfinder2.census.gov • 2010 US Census - population and demographic profiles • American Community Survey - socioeconomic status • Local EPI profile and community plan

  23. Next Steps…

  24. Next Planning Steps • LHJs will work on development of testing plans using worksheets and format as described by OA (to be provided) • Using your Epi data and HIV Community Plans, prioritize Tier I activities in your new prevention program • Assess current Tier I activities that can continue and contribute to your prevention program • Identify gaps in activities or target populations that will need additional resources or new activities developed • Submit Plans to OA on worksheets and format provided by OA

  25. Calendar of Upcoming webinars The following webinars will be held from 3-4pm on the dates listed below: • October 27 – PWP Activities • November 3 – Policy Initiatives • November 10 - Syringe Service Programs & California AIDS Clearinghouse • November 17 - Tier II Activities (Social Marketing, HE/RR for High Risk Negatives, Hepatitis C Testing, PrEP) • December 8 – Putting it all Together

  26. Questions or comments? If you have any questions or feedback at any time before or after the webinars please send them to: OAFeedback@cdph.ca.gov

More Related